- The increasing number of stem cell transplantations and the advancements in treatment approaches are some of the major factors driving the market growth
- In addition, development of novel therapies are further propelling the market growth. However, the major restraint that is impacting the market growth is the high cost associated with treatment
- On the other hand, increasing awareness and education about GVHD among healthcare providers, patients, and caregivers are expected to create an opportunity for market growth. However, the risk of infections and other complications is expected to pose a challenge to market growth
- North America remains a dominant region in the North America Graft-Versus-Host Disease (GVHD) Treatment market, supported by well-established healthcare infrastructure, high prevalence rates, and continuous research in weight management solutions
- With a growing emphasis on Graft-Versus-Host Disease (GVHD)management and preventive healthcare, the North America market is witnessing significant investments in novel therapies, medical technologies, and patient-centric solutions, driving overall industry expansion
